Thank you for your interest
Listen to the Podcast below or view a Transcript of the Podcast here
Engineering NK Cells for Enhanced Potency and Persistence
James B. Trager, PhD, Senior Vice President, Research and Development, Nkarta Therapeutics
Dr. James Trager shares a preview of his talk at the NK cell-based cancer immunotherapy meeting in Boston, discusses his next step in research and the vision of Nkarta in NK cell therapy development and what he’s looking forward to at this meeting
such as the topics of inhibition of MIC protein shedding and NK cell metabolism.